Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? (2013)
- Authors:
- USP affiliated authors: PONTILLO, ALESSANDRA - ICB ; DUARTE, ALBERTO JOSE DA SILVA - FM
- Unidades: ICB; FM
- DOI: 10.2217/imt.13.136
- Assunto: IMUNOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Immunotherapy
- ISSN: 1750-7448
- Volume/Número/Paginação/Ano: v. 5, n. 12, p. 1305-1311, 2013
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SILVA, Lais Teodoro da et al. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine?. Immunotherapy, v. 5, n. 12, p. 1305-1311, 2013Tradução . . Disponível em: https://doi.org/10.2217/imt.13.136. Acesso em: 14 fev. 2026. -
APA
Silva, L. T. da, Pontillo, A., Silva, W. C. da, Almeida, A. de, Duarte, A. J. da S., & Oshiro, T. M. (2013). Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? Immunotherapy, 5( 12), 1305-1311. doi:10.2217/imt.13.136 -
NLM
Silva LT da, Pontillo A, Silva WC da, Almeida A de, Duarte AJ da S, Oshiro TM. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? [Internet]. Immunotherapy. 2013 ; 5( 12): 1305-1311.[citado 2026 fev. 14 ] Available from: https://doi.org/10.2217/imt.13.136 -
Vancouver
Silva LT da, Pontillo A, Silva WC da, Almeida A de, Duarte AJ da S, Oshiro TM. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? [Internet]. Immunotherapy. 2013 ; 5( 12): 1305-1311.[citado 2026 fev. 14 ] Available from: https://doi.org/10.2217/imt.13.136 - Polymorphisms in TREX1 and susceptibility to HIV-1 infection
- Susceptibility to Mycobacterium tuberculosis Infection in HIV-Positive Patients Is Associated With CARD8 Genetic Variant
- Differential inflammasome expression and IL-1β secretion in monocyte-derived dendritic cells differentiated with IL-4 or IFN-α
- Contribution of inflammasome genetics in Plasmodium vivax malaria
- NLRP3 polymorphism is associated with protection against human T-lymphotropic virus 1 infection
- Differential expression of the inflammasome complex genes in systemic lupus erythematosus
- Role of C–C chemokine receptor type 5 in pathogenesis of malaria and its severe forms
- Inflammasome genetics contributes to the development and control of active pulmonary tuberculosis
- Role of inflammasome genetics in susceptibility to HPV infection and cervical cancer development
- Gain-of-function SNPs in NLRP3 and ILIB genes confer protection against obesity T2D: undiscovered role of inflammasome genetics in metabolic homeostasis?
Informações sobre o DOI: 10.2217/imt.13.136 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
